Active Case
Oxbryta
Vaso-occlusive crises, stroke and death alleged from Oxbryta
You took a drug approved to help you. That is not your fault.
Pfizer pulled Oxbryta from the market in 2024. The lawsuits are in early stages, with a first trial set for 2027. This page tracks what the record shows.
Register Your InterestInvestigations
What we found
Every article is based on court documents, internal company research, peer-reviewed studies, and public records.